Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
26.29
-0.22 (-0.83%)
At close: Feb 26, 2026, 4:00 PM EST
26.21
-0.08 (-0.30%)
After-hours: Feb 26, 2026, 7:55 PM EST
RGC Market Cap
RGC has a market cap or net worth of $13 billion as of February 26, 2026. Its market cap has increased by 26,647.65% in one year.
Market Cap
13.00B
Enterprise Value
13.00B
1-Year Change
26,647.65%
Ranking
Category
Stock Price
$26.29
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $13.00B, an increase of 10,724.41%. That is a compound annual growth rate of 175.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 13.11B | 26.24% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 45.57B |
| Teva Pharmaceutical Industries | 39.13B |
| United Therapeutics | 21.46B |
| Viatris | 17.81B |
| Elanco Animal Health | 13.19B |
| Neurocrine Biosciences | 12.99B |
| Dr. Reddy's Laboratories | 12.08B |
| Alkermes | 5.04B |